Free Trial
→ Warren Buffett Issues Cryptic Warning on U.S. Dollar (From Banyan Hill Publishing) (Ad)tc pixel

Oxford BioMedica (OTCMKTS:OXBDF) Hits New 52-Week High - Still a Buy?

Written by MarketBeat
Updated August 26, 2025
Oxford BioMedica logo with Medical background

Key Points

  • Oxford BioMedica's shares reached a new 52-week high of $6.82 during trading, closing at $6.73 with a volume of 10,900 shares.
  • The company specializes in advanced gene delivery systems through its LentiVector platform, addressing safety issues associated with earlier vector technologies.
  • Oxford BioMedica has seen significant growth, with 50-day and 200-day moving averages at $5.19 and $4.47, respectively, indicating positive price momentum.
  • Five stocks we like better than Oxford BioMedica.

Shares of Oxford BioMedica (OTCMKTS:OXBDF - Get Free Report) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $6.82 and last traded at $6.73, with a volume of 10900 shares traded. The stock had previously closed at $6.72.

Oxford BioMedica Stock Performance

The stock has a 50-day simple moving average of $5.35 and a 200 day simple moving average of $4.51.

Oxford BioMedica Company Profile

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

Featured Articles

Should You Invest $1,000 in Oxford BioMedica Right Now?

Before you consider Oxford BioMedica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford BioMedica wasn't on the list.

While Oxford BioMedica currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best Nuclear Energy Stocks to Buy Cover
The Best Nuclear Energy Stocks to Buy

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.